VentrAssistTM LVAD as a Bridge to Cardiac Transplantation - Feasibility Trial

Completed · Phase 2

Conditions studied: End-Stage Heart Failure, Cardiomyopathies

In brief

The purpose of this trial is to determine the safety and feasibility of the VentrAssist LVAD in providing circulatory support for patients who require an LVAD as a bridge to cardiac transplantation.

Key facts

Study ID

NCT00490347

Run by

Ventracor

People needed

30

Starts

2005-07-01

Expected to finish

2007-10-01

Last updated by the study team

2008-01-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Maryland Medical Center - Baltimore — Baltimore, Maryland, United States
• University of Minnesota Medical Center - Fairview — Minneapolis, Minnesota, United States
• New York Presbyterian Medical Center - Columbia — New York, New York, United States
• Cleveland Clinic Foundation — Cleveland, Ohio, United States
• University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.